Ben-Tzvi Avraham bought INDP
December 23, 2025 · Form 4 insider transaction
Ben-Tzvi Avraham bought 25,000 shares of Indaptus Therapeutics, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 30 days after the transaction.
Direction
Acquired (buy-side)
Shares
25,000
Price
$0.00
Total value
N/A
InsiderBen-Tzvi Avraham
Role—
SecurityOption to Buy Common Stock
Transaction codeA: Grant or award
Transaction dateDecember 23, 2025
Filing dateJanuary 22, 2026
Shares owned after25,000
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
The Reporting Person acquired options to purchase 25,000 shares of common stock pursuant to the Issuer's non-employee director compensation program. The stock options vest over three years commencing from the date of grant in equal quarterly installments subject to continued service on the Board through each vesting date.